288 related articles for article (PubMed ID: 28250297)
1. Multimodal Treatment of Vasoactive Intestinal Polypeptide-producing Pancreatic Neuroendocrine Tumors with Liver Metastases.
Iwasaki M; Tsuchida K; Jinnai H; Komatsubara T; Arisaka T; Tsunemi M; Nakano M; Iijima M; Hiraishi H
Intern Med; 2017; 56(5):517-522. PubMed ID: 28250297
[TBL] [Abstract][Full Text] [Related]
2. Is surgery indicated for patients with symptomatic nonfunctioning pancreatic neuroendocrine tumor and unresectable hepatic metastases?
Hung JS; Chang MC; Lee PH; Tien YW
World J Surg; 2007 Dec; 31(12):2392-7. PubMed ID: 17960455
[TBL] [Abstract][Full Text] [Related]
3. Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors.
Strosberg JR; Choi J; Cantor AB; Kvols LK
Cancer Control; 2006 Jan; 13(1):72-8. PubMed ID: 16508629
[TBL] [Abstract][Full Text] [Related]
4. [Two cases of neuroendocrine tumors of the pancreas with multiple liver metastases treated by use of degradable starch microspheres and octreotide].
Goto W; Shimizu S; Kotsuka M; Sakae M; Kanazawa A; Tsukamoto T; Yamashita Y; Nishiguchi Y
Gan To Kagaku Ryoho; 2014 Nov; 41(12):2139-41. PubMed ID: 25731449
[TBL] [Abstract][Full Text] [Related]
5. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.
Fiore F; Del Prete M; Franco R; Marotta V; Ramundo V; Marciello F; Di Sarno A; Carratù AC; de Luca di Roseto C; Colao A; Faggiano A
Endocrine; 2014 Sep; 47(1):177-82. PubMed ID: 24385266
[TBL] [Abstract][Full Text] [Related]
6. Management of pancreatic neuroendocrine tumors.
Dickson PV; Behrman SW
Surg Clin North Am; 2013 Jun; 93(3):675-91. PubMed ID: 23632152
[TBL] [Abstract][Full Text] [Related]
7. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
[TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine Tumors.
Basuroy R; Srirajaskanthan R; Ramage JK
Gastroenterol Clin North Am; 2016 Sep; 45(3):487-507. PubMed ID: 27546845
[TBL] [Abstract][Full Text] [Related]
9. Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report.
Case CC; Wirfel K; Vassilopoulou-Sellin R
Med Oncol; 2002; 19(3):181-7. PubMed ID: 12482130
[TBL] [Abstract][Full Text] [Related]
10. Significant efficacy of new transcatheter arterial chemoembolization technique for hepatic metastases of pancreatic neuroendocrine tumors.
Akahori T; Sho M; Tanaka T; Nishiofuku H; Kinoshita S; Nagai M; Kichikawa K; Nakajima Y
Anticancer Res; 2013 Aug; 33(8):3355-8. PubMed ID: 23898103
[TBL] [Abstract][Full Text] [Related]
11. Islet Cell Tumors of the Pancreas.
Amin S; Kim MK
Gastroenterol Clin North Am; 2016 Mar; 45(1):83-100. PubMed ID: 26895682
[TBL] [Abstract][Full Text] [Related]
12. Additional hepatic
Braat AJAT; Kwekkeboom DJ; Kam BLR; Teunissen JJM; de Herder WW; Dreijerink KMA; van Rooij R; Krijger GC; de Jong HWAM; van den Bosch MAAJ; Lam MGEH
BMC Gastroenterol; 2018 Jun; 18(1):84. PubMed ID: 29902988
[TBL] [Abstract][Full Text] [Related]
13. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs.
de Baere T; Deschamps F; Tselikas L; Ducreux M; Planchard D; Pearson E; Berdelou A; Leboulleux S; Elias D; Baudin E
Eur J Endocrinol; 2015 Apr; 172(4):R151-66. PubMed ID: 25385817
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary management of nonfunctional neuroendocrine tumor of the pancreas.
Folkert IW; Hernandez P; Roses RE
World J Gastroenterol; 2016 Mar; 22(11):3105-16. PubMed ID: 27003988
[TBL] [Abstract][Full Text] [Related]
15. Concomitant Case of Intraductal Papillary Mucinous Neoplasm of the Pancreas and Functioning Pancreatic Neuroendocrine Tumor (Vasoactive Intestinal Polypeptide-Producing Tumor): First Report.
Ishizu S; Setoyama T; Ueo T; Ueda Y; Kodama Y; Ida H; Kawaguchi Y; Yoshizawa A; Chiba T; Miyamoto S
Pancreas; 2016 Jul; 45(6):e24-5. PubMed ID: 27295534
[No Abstract] [Full Text] [Related]
16. Small Cystic Pancreatic Neuroendocrine Neoplasm with Huge Liver and Bone Metastases.
Yasuda M; Takeda S; Lee M; Hoshi S; Hoshi T; Tanaka Y; Miyajima S; Takaya H; Kajimura K
Intern Med; 2020; 59(23):3027-3032. PubMed ID: 33268697
[TBL] [Abstract][Full Text] [Related]
17. [Long-Term Survival with Multidisciplinary Therapy for Rectal NET with Liver Metastases--A Case Report].
Shinke G; Noda T; Hatano H; Hirota M; Takata A; Oshima K; Tanida T; Komori T; Morita S; Imamura H; Iwazawa T; Akagi K; Dono K
Gan To Kagaku Ryoho; 2015 Nov; 42(12):1872-4. PubMed ID: 26805201
[TBL] [Abstract][Full Text] [Related]
18. Complete remission of inoperable hepatic and bone metastases due to neuroendocrine pancreatic tumour 3 years after peptide receptor radionucleotide therapy.
Soeiro P; Martins H; Silva R; Moreira AP
BMJ Case Rep; 2020 Mar; 13(3):. PubMed ID: 32234855
[No Abstract] [Full Text] [Related]
19. Diffuse Bone Metastases in Pancreatic Neuroendocrine Tumor Shown on Octreoscan.
Adkins J; Lu Y
Clin Nucl Med; 2019 Mar; 44(3):257-258. PubMed ID: 30624276
[TBL] [Abstract][Full Text] [Related]
20. [The somatostatin analog SMS 201-995 in long-term treatment of vipoma].
Christensen C
Ugeskr Laeger; 1990 Dec; 152(51):3851-3. PubMed ID: 2177234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
